NCT05654246

Brief Summary

ShareForCures (SFC) is a community-based participatory research registry, and its prime objective is to engage participants representative of the United States breast cancer patient population -including minoritized and historically marginalized people, persons, or communities-to ensure the data researchers use to study breast cancer is as diverse as the people touched by this disease. In doing so, researchers will have a better understanding of breast cancer, and everyone can potentially benefit from scientific advances and improvements in care.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200,000

participants targeted

Target at P75+ for all trials

Timeline
79mo left

Started Nov 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress35%
Nov 2022Nov 2032

Study Start

First participant enrolled

November 17, 2022

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

December 8, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 16, 2022

Completed
9.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2032

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2032

Last Updated

March 6, 2026

Status Verified

March 1, 2026

Enrollment Period

10 years

First QC Date

December 8, 2022

Last Update Submit

March 4, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Engage participants representative of the United States breast cancer patient population in ShareForCures.

    Enroll and engage up to 200,000 people, who have been diagnosed with breast cancer, reflecting the diversity of breast cancer survivors within the United States, to participate in the registry as our partners in research.

    10 years

  • Integrate participant data into ShareForCures.

    Collect and curate a rich scope of participant data from a variety of sources (including participant-provided information, clinical records, and linkage to other existing datasets) and biospecimens to create a comprehensive, longitudinal database.

    10 years

  • Facilitate scientific research using ShareForCures data.

    Make deidentified data available to researchers for scientific discoveries, including research that may lead to new knowledge about breast cancer and advances in patient care and outcomes.

    10 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

ShareForCures is open to all individuals diagnosed with breast cancer, age 18 and older, of any gender, and all racial and ethnic origins living in the United States.

You may qualify if:

  • Individuals must be at least 18 years old. (Individuals in Alabama and Nebraska must be over 19 and individuals in Mississippi and Pennsylvania must be over 21 to participate).
  • Individuals must have been diagnosed with cancer originating (or is suspected to originate) from the breast.
  • Individuals must be currently residing in the United States or a territory of the United States.
  • Individuals must be able to read and understand English.

You may not qualify if:

  • Individuals under the age of 18 years. (Individuals in Alabama and Nebraska under 19 and individuals in Mississippi and Pennsylvania under 21 are not eligible to participate).
  • Individuals without a diagnosis of breast cancer.
  • Individuals who are not residing in the United States or a territory of the United States.
  • Individuals unable to read and understand English.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Susan G. Komen

Dallas, Texas, 75380, United States

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

ShareForCures plans to leverage different types of biospecimens, including breast cancer tissue (retrospective), blood (retrospective and prospective), and saliva (prospective).

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Jerome Jourquin, Ph.D., M.S.

    Susan G. Komen

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jerome Jourquin, Ph.D., M.S.

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 8, 2022

First Posted

December 16, 2022

Study Start

November 17, 2022

Primary Completion (Estimated)

November 1, 2032

Study Completion (Estimated)

November 1, 2032

Last Updated

March 6, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

Researchers may request access to SFC data, and upon approval may use the data to answer research questions including studies that will lead to new knowledge about breast cancer and advances in patient care and outcomes. All data sharing will be handled securely and under IRB approval or exemption, following rigorous standards to protect individual privacy and data confidentiality.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Once enough data have been aggregated in ShareForCures, researchers will be able to request access to ShareForCures deidentified data. Data will be available for the duration of the study.
Access Criteria
Researchers will be required to formally request access to the data. All requests will be reviewed according to Komen\'s Data Request Review Process. Researchers will also need to execute a Data Transfer and Use Agreement (DTUA), comply with the Researcher Code of Conduct, and abide by other Komen policies and procedures, as needed.
More information

Locations